Synthomer PLC Post-close trading update (2923G)
18 Luglio 2023 - 8:00AM
UK Regulatory
TIDMSYNT
RNS Number : 2923G
Synthomer PLC
18 July 2023
Synthomer plc
Post-close trading update
Synthomer plc ('Synthomer' or 'the Group') today announces an
update regarding trading for the six months ended 30 June 2023 (the
'period') and our outlook for the remainder of 2023.
Group trading
Continuing Group revenue in the period was GBP1.1bn with EBITDA
expected to be in the range of GBP72-74m, broadly consistent with
the Board's expectations described in our 2022 results announcement
in March. Continuing Group EBITDA in the second quarter was higher
than the first, notwithstanding the challenging macroeconomic
conditions throughout the period. Robust pricing and our strong
focus on margins helped to mitigate substantially lower volumes
compared with the first half of 2022, a consequence of destocking,
subdued levels of demand across most of our end markets and
increased competition in some of our base chemical product
ranges.
We continued to focus on cash generation during the period, with
reductions in capital expenditure, working capital and costs across
the Group. As at 30 June 2023, net debt was c.GBP795m, with net
debt:EBITDA on a leverage covenant basis of 5.5 times and committed
liquidity of more than GBP400m.
Divisional update
All divisions continued to make progress against their key
priorities, including delivery of our refreshed strategy as
announced last October. Those parts of our portfolio identified as
the more speciality, higher growth areas in our strategy review
proved the most resilient during the period and are already
beginning to benefit from our differentiated focus and
investment.
Coatings & Construction Solutions (CCS) is achieving robust
pricing and margins, with improved trading performance over the
period compared with the last quarter of 2022 despite cautious
customer buying behaviour. In line with our strategy, CCS recently
implemented several actions to broaden geographic and customer
penetration which will strengthen organic growth and increase
market share over time, while enhancing margins.
The performance of Adhesive Solutions (AS) in the period
continues to reflect the lower volume environment as well as the
previously disclosed operational reliability and supply chain
challenges in the adhesive resins business, acquired in early 2022.
We expect our reliability and performance improvement measures to
have a positive impact in the second half of the year, despite
continued demand weakness. We also recently committed to expand our
speciality amorphous polyolefins capacity in North America to
support growth in this region.
In Heath & Protection and Performance Materials (HPPM), the
challenging medical glove market dynamics which followed the
unprecedented activity during the pandemic continue. In line with
previous indications, we do not expect low nitrile butadiene rubber
(NBR) production levels to abate before the end of 2023. We
continue to focus on capacity management and cost control.
Our non-core portfolio rationalisation programme continued to
progress during the period.
Update on outlook
The Board does not anticipate a material recovery in customer
demand before the end of the current year. However, we anticipate
c.GBP20m in self-help measures expected mainly in H2. Overall the
Group remains confident of making sequential progress in the second
half relative to the first.
The Group continues to take decisive action to strengthen our
business so that it is positioned for profitable growth when demand
does begin to recover. We remain confident in our ability to
execute our refreshed strategy and deliver the medium-term targets
set out last October, which were mid-single-digit growth in
constant currency over the cycle, EBITDA margins above 15% and
mid-teens return on invested capital.
Synthomer will report half year results for the six months to 30
June on 7 September 2023.
Further information:
Investors: Faisal Tabbah, Vice President Investor Relations Tel: +44 (0) 1279 775 306
Media: Charles Armitstead, Teneo Tel: +44 (0) 7703 330 269
Notes
Legal Entity Identifier (LEI): 213800EHT3TI1KPQQJ56.
Classification as per DTR 6 Annex 1R: 3.1.
Synthomer plc is a leading supplier of high-performance,
specialty polymers and ingredients for coatings, construction,
adhesives, and healthcare end markets. Headquartered in London, UK
and listed there since 1971, we employ around 4,400 employees
across nearly 40 locations across Europe, USA and Asia. With more
than 6,000 customers and GBP2.4bn in continuing revenue in 2022,
our three divisions are aligned to our end markets which play an
important role in global megatrends including urbanisation, climate
change, and economic and demographic shifts. In Coatings &
Construction Solutions, our tailored solutions enhance the
sustainability and performance of a range of products such as
architectural and masonry coatings, mortar modification, fibre
bonding, waterproofing and flooring, while our energy solutions
promote drilling stability in the challenging operating
environments of the oil and gas industry. Adhesive Solutions is a
leading supplier of products that bond, modify and compatibilise
surfaces and components for a range of end markets including tapes
and labels, packaging, hygiene, tyres and plastics. In Health &
Protection and Performance Materials we are a world-leading
supplier of water-based polymers for medical gloves and a major
European manufacturer of high-performance binders, foams and other
products for a range of niche applications. Our purpose is creating
innovative and sustainable solutions for the benefit of customers
and society. Around 20% of our sales volumes are from new and
patent protected products. At our innovation hubs in the UK,
Germany, Malaysia and Ohio, USA we collaborate closely with our
customers to develop new products tailored to their needs while
also minimising environmental impact. We are working to embed
sustainability in everything we do; we have reduced our scope 1 and
2 carbon footprint by one third since 2019, and our 2030
decarbonisation targets have been approved by the Science Based
Targets initiative as being in line with what the latest climate
science says is necessary to meet the goals of the Paris Agreement.
Since 2021 we have held the London Stock Exchange Green Economy
Mark, which recognises green technology businesses making a
significant contribution to a more sustainable, low-carbon economy.
Find us at www.synthomer.com , @Synthomer_Group on Twitter or
search for Synthomer on LinkedIn.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TSTGPUCGMUPWGBM
(END) Dow Jones Newswires
July 18, 2023 02:00 ET (06:00 GMT)
Grafico Azioni Synthomer (LSE:SYNT)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Synthomer (LSE:SYNT)
Storico
Da Apr 2023 a Apr 2024